Extraction of Vital Signs using a Telehealth Application for Asthma - EViTA-AThe purpose of this grant is to evaluate mobile devices to extract vitals signs to monitor patients with Asthma

使用哮喘远程医疗应用程序提取生命体征 - EViTA-A 这项拨款的目的是评估移动设备提取生命体征以监测哮喘患者

基本信息

  • 批准号:
    10699530
  • 负责人:
  • 金额:
    $ 45.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-19 至 2024-09-18
  • 项目状态:
    已结题

项目摘要

Asthma is a chronic disease that affects quality of life, productivity, and healthcare use, and can ultimately lead to death. The costs of asthma are largely due to uncontrolled disease and accordingly rise as its prevalence and severity increase. Unfortunately, the incidence and impact of asthma attacks have not improved despite widespread adoption of effective universal treatment guidelines by healthcare providers, revealing an unmet need to facilitate implementation and monitoring of large groups of asthma patients. We seek to improve the detection of the presence and severity of an asthma attack for proper triage of patients to receive immediate medical treatment versus continued observation at home. Telemedicine provides an opportunity for better management, but these visual and verbal evaluations are often incomplete without vital sign measurements. Our approach of remote monitoring with video-based vital sign capture offers a game-changing alternative to address asthma attacks upon their initial presentation and prevention through improved management of chronic asthma symptoms. This innovative technology will: (i) extend the reach for physicians and accessibility for patients; (ii) improve efficiency of healthcare delivery to the highest risk patients; (iii) limit exposure to infectious disease for both patient and provider; and (iv) utilize common (relatively) commercial off the shelf (COTS) technologies instead of expensive boutique equipment. The distinguishing characteristics of asthma (inflammation, airway hyperreactivity and remodeling) are the expression of a unique and complex set of molecular interactions that also manifest as symptoms and changes in behavior that result in observed clinical phenotypes. Our next steps are to enhance remote medical monitoring with extracted vital signs by developing a biopsychosocial approach to refine phenotypes of asthma. Ultimately, the approach here will enhance the data gathered from each digital touchpoint to improve early detection of acute health status before more costly interventions are needed, thereby improving quality of life, and providing lower SES patients with asthma or other respiratory illnesses a more viable means to obtaining access to healthcare.
哮喘是一种影响生活质量、生产力和医疗保健使用的慢性疾病, 最终导致死亡。哮喘的费用主要是由于不受控制的疾病, 随着其发病率和严重程度的增加而相应增加。不幸的是, 尽管广泛采用了有效的普遍治疗, 医疗保健提供者的指南,揭示了未满足的促进实施的需求, 监测大组哮喘患者。我们试图改善对存在的检测 哮喘发作的严重程度,以便对患者进行适当的分类, 治疗与在家继续观察。远程医疗提供了一个机会, 管理,但这些视觉和口头评估往往是不完整的,没有生命体征 测量.我们的远程监控方法与基于视频的生命体征采集提供了一个 改变游戏规则的替代方案,以解决哮喘发作后,他们的初步介绍, 通过改善慢性哮喘症状的管理来预防。这一创新 技术将:(一)扩大医生的覆盖范围和患者的可及性;(二)改善 向最高风险患者提供医疗保健的效率;(iii)限制接触传染病 患者和提供者的疾病;以及(iv)利用常见的(相对)商业现成的 (COTS)技术,而不是昂贵的精品设备。区别特性 哮喘(炎症,气道高反应性和重塑)是一种独特的表达, 以及一系列复杂的分子相互作用,也表现为症状和变化 导致观察到的临床表型的行为。我们的下一步是增强远程 通过开发生物心理社会方法, 哮喘的表型最终,这里的方法将增强从每个 数字接触点,以改善急性健康状况的早期检测, 需要进行干预,从而改善生活质量,并为SES较低的患者提供 哮喘或其他呼吸道疾病是获得医疗保健的更可行的手段。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven Myers其他文献

Steven Myers的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.91万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 45.91万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.91万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.91万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.91万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.91万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.91万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 45.91万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 45.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 45.91万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了